Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesions
Purpose: to report cases of persistent diabetic macular edema (DME) with vitreomacular adhesions (VMA) that responded to intravitreal bevacizumab (IVB) injection with separation of the VMA and complete or significant resolution of DME Methods: Three eyes of three patients were diagnosed with persist...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| التنسيق: | article |
| منشور في: |
2012
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/10879 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://iovs.arvojournals.org/article.aspx?articleid=2349233 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513487532720128 |
|---|---|
| author | Al Judaibi, Ramzi M. |
| author2 | Al Shamsi, Hanan Ghazi, Nicola G. |
| author2_role | author author |
| author_facet | Al Judaibi, Ramzi M. Al Shamsi, Hanan Ghazi, Nicola G. |
| author_role | author |
| dc.creator.none.fl_str_mv | Al Judaibi, Ramzi M. Al Shamsi, Hanan Ghazi, Nicola G. |
| dc.date.none.fl_str_mv | 2012 2019-06-21T06:44:08Z 2019-06-21T06:44:08Z 2019-06-21 |
| dc.identifier.none.fl_str_mv | 1552-5783 http://hdl.handle.net/10725/10879 Al Judaibi, R. M., Al Shamsi, H., & Ghazi, N. G. (2012). Intravitreal Bevacizumab Injections can Release Vitreomacular Adhesions in Eyes with Persistent Diabetic Macular Edema and Vitreomacular Adhesions. Investigative Ophthalmology & Visual Science, 53(14), 416-416. http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://iovs.arvojournals.org/article.aspx?articleid=2349233 |
| dc.language.none.fl_str_mv | en |
| dc.relation.none.fl_str_mv | Investigative Ophthalmology & Visual Science |
| dc.rights.*.fl_str_mv | info:eu-repo/semantics/openAccess |
| dc.title.none.fl_str_mv | Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesions |
| dc.type.none.fl_str_mv | Article info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/article |
| description | Purpose: to report cases of persistent diabetic macular edema (DME) with vitreomacular adhesions (VMA) that responded to intravitreal bevacizumab (IVB) injection with separation of the VMA and complete or significant resolution of DME Methods: Three eyes of three patients were diagnosed with persistent DME and VMA following focal laser therapy based on typical clinical, angiographic, and spectral-domain optical coherence tomography (SD-OCT, Spectralis, Heidelberg, Germany) findings. A trial of IVB was attempted prior to proceeding with pars plana vitrectomy (PPV) to address the VMA. Results: All eyes disclosed cystoid macular edema with perifoveal vitreous separation and focal adhesion of the posterior hyaloid at the fovea on SD-OCT. Following one to three injections of IVB, SD-OCT showed complete separation of the VMA in all eyes with complete or significant resolution of the intraretinal fluid. Conclusions: Our findings suggest that a trial of intravitreal therapy, such as IVB, should be attempted in eyes with persistent DME and focal VMA before proceeding to PPV. The mechanical effect of the intravitreal injections may lead to separation of the VMA. This, together with the pharmacological effect of the injected agent, may lead to resolution of the DME as seen in the cases reported herein. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | LAURepo_e4aa6d137066ac271d8779f8e5c03d7f |
| identifier_str_mv | 1552-5783 Al Judaibi, R. M., Al Shamsi, H., & Ghazi, N. G. (2012). Intravitreal Bevacizumab Injections can Release Vitreomacular Adhesions in Eyes with Persistent Diabetic Macular Edema and Vitreomacular Adhesions. Investigative Ophthalmology & Visual Science, 53(14), 416-416. |
| language_invalid_str_mv | en |
| network_acronym_str | LAURepo |
| network_name_str | Lebanese American University repository |
| oai_identifier_str | oai:laur.lau.edu.lb:10725/10879 |
| publishDate | 2012 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| spelling | Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesionsAl Judaibi, Ramzi M.Al Shamsi, HananGhazi, Nicola G.Purpose: to report cases of persistent diabetic macular edema (DME) with vitreomacular adhesions (VMA) that responded to intravitreal bevacizumab (IVB) injection with separation of the VMA and complete or significant resolution of DME Methods: Three eyes of three patients were diagnosed with persistent DME and VMA following focal laser therapy based on typical clinical, angiographic, and spectral-domain optical coherence tomography (SD-OCT, Spectralis, Heidelberg, Germany) findings. A trial of IVB was attempted prior to proceeding with pars plana vitrectomy (PPV) to address the VMA. Results: All eyes disclosed cystoid macular edema with perifoveal vitreous separation and focal adhesion of the posterior hyaloid at the fovea on SD-OCT. Following one to three injections of IVB, SD-OCT showed complete separation of the VMA in all eyes with complete or significant resolution of the intraretinal fluid. Conclusions: Our findings suggest that a trial of intravitreal therapy, such as IVB, should be attempted in eyes with persistent DME and focal VMA before proceeding to PPV. The mechanical effect of the intravitreal injections may lead to separation of the VMA. This, together with the pharmacological effect of the injected agent, may lead to resolution of the DME as seen in the cases reported herein.PublishedN/A2019-06-21T06:44:08Z2019-06-21T06:44:08Z20122019-06-21Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1552-5783http://hdl.handle.net/10725/10879Al Judaibi, R. M., Al Shamsi, H., & Ghazi, N. G. (2012). Intravitreal Bevacizumab Injections can Release Vitreomacular Adhesions in Eyes with Persistent Diabetic Macular Edema and Vitreomacular Adhesions. Investigative Ophthalmology & Visual Science, 53(14), 416-416.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttps://iovs.arvojournals.org/article.aspx?articleid=2349233enInvestigative Ophthalmology & Visual Scienceinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/108792021-03-19T10:45:19Z |
| spellingShingle | Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesions Al Judaibi, Ramzi M. |
| status_str | publishedVersion |
| title | Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesions |
| title_full | Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesions |
| title_fullStr | Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesions |
| title_full_unstemmed | Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesions |
| title_short | Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesions |
| title_sort | Intravitreal bevacizumab injections can release vitreomacular adhesions in eyes with persistent diabetic macular edema and vitreomacular adhesions |
| url | http://hdl.handle.net/10725/10879 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://iovs.arvojournals.org/article.aspx?articleid=2349233 |